Retraction Note: JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy (Scientific Reports, (2014), 4, 1, (4694), 10.1038/srep04694);JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Sui, Xinbing ^a,b   Kong, Na ^a,b   Wang, Xian ^a,b   Fang, Yong ^a   Hu, Xiaotong ^b   Xu, Yinghua ^a   Chen, Wei ^a   Wang, Kaifeng ^a   Li, Da ^a   Jin, Wei ^a   Lou, Fang ^a   Zheng, Yu ^a   Hu, Hong ^a   Gong, Liu ^a   Zhou, Xiaoyun ^a   Pan, Hongming ^a,b   Han, Weidong ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b Key Laboratory of Biotherapy of Zhejiang Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; ANTINEOPLASTIC ANTIMETABOLITE; APOPTOSIS REGULATORY PROTEIN; ATG5 PROTEIN, HUMAN; BECN1 PROTEIN, HUMAN; FLUOROURACIL; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN BCL 2; PROTEIN P53; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; AUTOPHAGY; BIOSYNTHESIS; COLON TUMOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; ENZYME ACTIVATION; GENETICS; HCT116 CELL LINE; HT 29 CELL LINE; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTHRACENES; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; FLUOROURACIL; HCT116 CELLS; HT29 CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84910110457     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-021-82870-5     Document Type: Erratum

References (38)

1. Karpiński, P., Sasiadek, M. M. & Blin, N. Aberrant epigenetic patterns in the etiology of gastrointestinal cancers. J Appl Genet 49, 1-10 (2008).
2. Herszényi, L. & Tulassay, Z. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 14, 249-258 (2010).
3. Sun, X. X., Dai, M. S. & Lu, H. 5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction. J Biol Chem 282, 8052-8059 (2007).
4. Subbarayan, P. R. et al. Chronic exposure of colorectal cancer cells in culture to fluoropyrimidine analogs induces thymidylate synthase and suppresses p53. A molecular explanation for the mechanism of 5-FU resistance. Anticancer Res 30, 1149-1156 (2010).
5. Huang, C. et al. The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells. Cancer Biol Ther 8, 2186-2193 (2009).
6. Sui, X. et al. p53 signaling and autophagy in cancer: A revolutionary strategy could be developed for cancer treatment. Autophagy 7, 565-571 (2011).
7. Altman, B. J. & Rathmell, J. C. Autophagy: not good OR bad, but good AND bad. Autophagy 5, 569-570 (2009).
8. Lum, J. J., DeBerardinis, R. J. & Thompson, C. B. Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol 6, 439-448 (2005).
9. Mizushima, N., Levine, B., Cuervo, A. M. & Klionsky, D. J. Autophagy fights disease through cellular self-digestion. Nature 451, 1069-1075 (2008).
10. Kondo, Y., Kanzawa, T., Sawaya, R. & Kondo, S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5, 726-734 (2005).
11. Chen, N. & Debnath, J. Autophagy and tumorigenesis. FEBS Lett 584, 1427-1435 (2010).
12. Høyer-Hansen, M. & Jäättelä, M. Autophagy: An emerging target for cancer therapy. Autophagy 4, 574-580 (2008).
13. Kelkel, M. et al. ROS-independent JNK activation and multisite phosphorylation of Bcl-2 link diallyl tetrasulfide-induced mitotic arrest to apoptosis. Carcinogenesis 33, 2162-2171 (2012).
14. Zhao, M. et al. HMGB1 regulates autophagy through increasing transcriptional activities of JNK and ERK in human myeloid leukemia cells. BMB Rep 44, 601-066 (2011).
15. Sau, A. et al. Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines. Mol Biosyst 8, 994-1006 (2012).
16. Li, Y. et al. Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells. PLoS One 7, e44254 (2012).
17. Zhu, B. et al. Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells. Int J Cancer 132, 2270-2282 (2013).
18. Song, X., Kim, S. Y. & Lee, Y. J. The role of Bcl-xL in synergistic induction of apoptosis by mapatumumab and oxaliplatin in combination with hyperthermia on human colon cancer. Mol Cancer Res 10, 1567-1579 (2012).
19. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8, 445-544 (2012).
20. Nilsson, J. R. Does chloroquine, an antimalarial drug, affect autophagy in Tetrahymena pyriformis? J Protozool 39, 9-16 (1992).
21. Sui, X. et al. Autophagy and Chemotherapy Resistance: A Promising Therapeutic Strategy for Cancer. Cell Death Dis 4, e838 (2013).
22. Notte, A., Ninane, N., Arnould, T. & Michiels, C. Hypoxia counteracts taxol-induced apoptosis in MDA-MB-231 breast cancer cells: role of autophagy and JNK activation. Cell Death Dis 4, e638 (2013).
23. Sun, T. et al. c-Jun NH2-terminal kinase activation is essential for up-regulation of LC3 during ceramide-induced autophagy in human nasopharyngeal carcinoma cells. J Transl Med 9, 161 (2011).
24. Brech, A., Ahlquist, T., Lothe, R. A. & Stenmark, H. Autophagy in tumour suppression and promotion. Mol Oncol 3, 366-375 (2009).
25. Chen, S. et al. Autophagy is a therapeutic target in anticancer drug resistance. Biochim Biophys Acta 1806, 220-229 (2010).
26. Choi, J. H., Yoon, J. S., Won, Y. W., Park, B. B. & Lee, Y. Y. Chloroquine enhances the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle alteration. APMIS 120, 597-604 (2012).
27. Li, J., Hou, N., Faried, A., Tsutsumi, S. & Kuwano, H. Inhibition of autophagy augments 5-fluorouracil chemotherapy in humancolon cancer in vitro and in vivo model. Eur J Cancer 46, 1900-1909 (2010).
28. Pan, X. et al. Autophagy inhibition promotes 5-fluorouraci-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells. PLoS One 8, e56679 (2013).
29. Wei, Y. et al. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell 30, 678-688 (2008).
30. Fuest, M. et al. The transcription factor c-Jun protects against sustained hepatic endoplasmic reticulum stress thereby promoting hepatocyte survival. Hepatology 55, 408-418 (2012).
31. Mansouri, A. et al. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 278, 19245-1956 (2003).
32. Xiao, F., Liu, B. & Zhu, Q. X. c-Jun N-terminal kinase is required for thermotherapy-induced apoptosis in human gastric cancer cells. World J Gastroenterol 18, 7348-7356 (2012).
33. Paillas, S. et al. MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy. Autophagy 8, 1098-1112 (2012).
34. O'Donovan, T. R., O'Sullivan, G. C. & McKenna, S. L. Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy 7, 509-524 (2011).
35. de la Cruz-Morcillo, M. A. et al. P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance. Oncogene 31, 1073-1085 (2012).
36. Sui, X. et al. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer lett 344, 174-179 (2014).
37. Chaanine, A. H. et al. JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure. Cell Death Dis 3, 265 (2012).
38. Hu, X. et al. Protocadherin 17 acts as a tumor suppressor inducing tumor cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers. J Pathol 229, 62-73 (2011).